⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ORGO News
Organogenesis Holdings Inc. Class A Common Stock
Organogenesis Completes Rolling Submission of Biologics License Application for ReNu®
globenewswire.com
ORGO
Organogenesis Holdings, Inc. Investigated by the Portnoy Law Firm
globenewswire.com
ORGO
Organogenesis Achieves Primary Endpoint in Randomized Controlled Trial of PuraPly®AM
globenewswire.com
ORGO
Organogenesis Announces Successful FDA Meeting and Plan to File BLA for ReNu® for Knee Osteoarthritis Pain
globenewswire.com
ORGO
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2026 Financial Results on May 7, 2026
globenewswire.com
ORGO
KELLS to Attend Centri Capital Conference on April 14 Ready to Announce with Confidence?
newsfilecorp.com
MS
DFIN
MVBF
ORGO
COIN
Form 8-K
sec.gov
ORGO
Organogenesis Holdings Inc. Reports Fourth Quarter 2025 Financial Results, Posts Record Revenue
globenewswire.com
ORGO
Form 8-K
sec.gov
ORGO
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 26, 2026
globenewswire.com
ORGO